Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection
about
Panel 5: Microbiology and immunology panelCurrent progress with Moraxella catarrhalis antigens as vaccine candidatesComprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance modelATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in VirulenceIdentification of a bacteriocin and its cognate immunity factor expressed by Moraxella catarrhalis.Panel 6: Vaccines.Genome analysis of Moraxella catarrhalis strain BBH18, [corrected] a human respiratory tract pathogen.Expression of urease by Haemophilus influenzae during human respiratory tract infection and role in survival in an acid environmentSubstrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalisSerum antibody response to Moraxella catarrhalis proteins OMP CD, OppA, Msp22, Hag, and PilA2 after nasopharyngeal colonization and acute otitis media in childrenVaccine targets against Moraxella catarrhalis.The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.Phagocytic dysfunction of human alveolar macrophages and severity of chronic obstructive pulmonary disease.Use of Moraxella catarrhalis lipooligosaccharide mutants to identify specific oligosaccharide epitopes recognized by human serum antibodies.Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.Molecular aspects of Moraxella catarrhalis pathogenesis.Bacterium-generated nitric oxide hijacks host tumor necrosis factor alpha signaling and modulates the host cell cycle in vitro.Moraxella catarrhalis: from interactions with the host immune system to vaccine development.Potential impact of a Moraxella catarrhalis vaccine in COPD.Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract.A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: an update on current progress and challenges.Serum antibody response to Moraxella catarrhalis proteins in stringently defined otitis prone children.A Cation-binding Surface Protein as a Vaccine Antigen to Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.Immunoinformatics Identifies a Lactoferrin Binding Protein A Peptide as a Promising Vaccine With a Global Protective Prospective Against Moraxella catarrhalis.Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract.Identification of domains of the Hag/MID surface protein recognized by systemic and mucosal antibodies in adults with chronic obstructive pulmonary disease following clearance of Moraxella catarrhalis.Identification of a repressor of a truncated denitrification pathway in Moraxella catarrhalis.Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.The Moraxella catarrhalis nitric oxide reductase is essential for nitric oxide detoxification.
P2860
Q26829692-F585F87C-23A5-4172-8FB7-BF1EA22761F0Q28304447-C652AC31-0D0F-46D5-B4A3-895EB8B25FA9Q28382833-E21AECF9-15BB-4C7A-8C7A-F58620C0107FQ28552490-8C65F2D0-C879-4CE4-9DDE-DF3C78057ADFQ33506769-4A6D5ED7-6B3E-4AAE-AE15-C7A65552C555Q33644678-22FA91B0-342F-4E94-A286-82875E1721D2Q33962997-554853EE-470A-409B-8EB7-1DFEA924AB7DQ33993457-E757AACF-B672-4481-AB8D-7BD18887E53FQ34058997-503EBDF2-AFF0-48E8-9F50-A072812CFB01Q35805451-E72E6AE7-5289-4581-B61B-AC81356E0B99Q36173789-AF0DEFB2-A271-46FB-955F-45CDD5A412ADQ36483998-F4622616-2038-4A3C-B048-D06591BEAAEAQ36513457-32C33564-FFDC-470A-9869-FCE3E8D78474Q37332198-F13D8B4A-A9CE-4614-92F6-9BEC2381C7CAQ37355837-2569B76F-F207-4BA2-B195-EE947292888AQ37441243-36DE062C-FF72-451C-9D3C-0585DED9F436Q37590025-A7275C35-1F64-4564-9B67-1393E5569A83Q38013610-33237972-8DD8-456C-85DC-979D0FEEF74BQ38041190-18958963-B91A-4C64-B9E1-D0E83A962E64Q39129692-9DE70870-5135-4806-A493-7C88B28AC11BQ39131974-8E5759A9-9946-4D9E-8427-8DF770F827D4Q40074756-07E71558-9186-4512-A82E-F580070D3AD0Q40114722-80A0C2CE-62F8-442A-AD74-A978624F15B3Q40154497-3873FBB2-41AE-4A8F-9A89-B21C3086E6D3Q40780023-E83DA6F9-5AFB-4022-8284-E79B38073C39Q41786495-A5EE9F12-DEA4-4A19-92D1-B4C856DBE186Q41839685-3EFCE33C-AE9C-4C9F-9276-BB23C25B6961Q41985791-C1767F7F-B404-402E-8D85-41CB41DC5524Q42583054-3B067D4C-446D-473C-9544-CA6743DA7166Q42792994-CE991D35-29AA-4EC2-A0DD-CE05585ADBDA
P2860
Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Mining the Moraxella catarrhal ...... pressed during human infection
@ast
Mining the Moraxella catarrhal ...... pressed during human infection
@en
type
label
Mining the Moraxella catarrhal ...... pressed during human infection
@ast
Mining the Moraxella catarrhal ...... pressed during human infection
@en
prefLabel
Mining the Moraxella catarrhal ...... pressed during human infection
@ast
Mining the Moraxella catarrhal ...... pressed during human infection
@en
P2093
P2860
P356
P1476
Mining the Moraxella catarrhal ...... pressed during human infection
@en
P2093
Alan J Lesse
Charmaine Kirkham
Elizabeth A Ruckdeschel
P2860
P304
P356
10.1128/IAI.01253-07
P407
P577
2008-01-28T00:00:00Z